This proposed pathway of immune cell crosstalk is also consistent with a very recent report that CD4+ type II NKT cells mediate ICOS and programmed death-1–dependent regulation of diabetogenic CD4+ T cells and protection from T1D [40]. The gene discussed is CD4; the disease is type 1 diabetes mellitus.